Effect of hepatogomax on serum alkaline phosphatase, bilirubin, gamma-glutamyl transferase levels in Sprague Dawley rats cirrhosis
Cirrhosis is the final stage of all chronic liver diseases. Complications that occur are malnutrition. Administration of Hepatogomax as an enteral formula with adequate nutrients, specifically Branched-Chain Amino Acids (BCAA) and Medium-chain Triglyceride (MCT), can reduce serum ALP, bilirubin, and...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Jurusan Gizi Politeknik Kesehatan Kemenkes Aceh
2023-06-01
|
| Series: | AcTion: Aceh Nutrition Journal |
| Subjects: | |
| Online Access: | https://ejournal.poltekkesaceh.ac.id/index.php/an/article/view/969 |
| _version_ | 1797397467331821568 |
|---|---|
| author | Elfrida Sianturi Hery Djagat Purnomo Adriyan Pramono Endang Mahati Etika R. Noer |
| author_facet | Elfrida Sianturi Hery Djagat Purnomo Adriyan Pramono Endang Mahati Etika R. Noer |
| author_sort | Elfrida Sianturi |
| collection | DOAJ |
| description | Cirrhosis is the final stage of all chronic liver diseases. Complications that occur are malnutrition. Administration of Hepatogomax as an enteral formula with adequate nutrients, specifically Branched-Chain Amino Acids (BCAA) and Medium-chain Triglyceride (MCT), can reduce serum ALP, bilirubin, and GG levels. This study aimed to determine the effect of hepatogomax in different doses on serum ALP, bilirubin, and GG levels. The study used the True Experimental post-test group design. Twenty-four male rats were divided into control group K normal and K(-) cirrhotic, treatment groups P1 and P2, given TAA and hepatogomax induction, respectively, at doses of 4,87 g/200gBW/day and 14,6 g/200gBW/day. Intervention for 28 days at the PAU Laboratory, Gadjah Mada University, February 2022 to April 2022. Statistical analysis used the Kruskal Wallis and Mann Whitney Post Hoc tests. The data is the result of examining serum levels after the intervention. The results showed significant differences in ALP, bilirubin, and GGT (p<0,05) in the group of rats induced by TAA intervention with hepatogomax compared to those not given hepatogomax. There was no significant difference in the decrease in serum ALP levels between the K normal (p<0,05) and P2 (p>0,05) groups. Giving hepatogomax at a dose of 14,6 g/200BB/day reduced serum ALP, bilirubin, and GG levels. In conclusion, Hepatogomax decreased ALP, bilirubin, and GGT serum levels in rats with cirrhosis. The most significant decrease in serum ALP, bilirubin, and GGT levels was observed at the P2 dose. |
| first_indexed | 2024-03-09T01:11:27Z |
| format | Article |
| id | doaj.art-344712b8b0ef4dc4873b16d61c5e961e |
| institution | Directory Open Access Journal |
| issn | 2527-3310 2548-5741 |
| language | English |
| last_indexed | 2024-03-09T01:11:27Z |
| publishDate | 2023-06-01 |
| publisher | Jurusan Gizi Politeknik Kesehatan Kemenkes Aceh |
| record_format | Article |
| series | AcTion: Aceh Nutrition Journal |
| spelling | doaj.art-344712b8b0ef4dc4873b16d61c5e961e2023-12-11T05:07:50ZengJurusan Gizi Politeknik Kesehatan Kemenkes AcehAcTion: Aceh Nutrition Journal2527-33102548-57412023-06-018224325110.30867/action.v8i2.969397Effect of hepatogomax on serum alkaline phosphatase, bilirubin, gamma-glutamyl transferase levels in Sprague Dawley rats cirrhosisElfrida Sianturi0Hery Djagat Purnomo1Adriyan Pramono2Endang Mahati3Etika R. Noer4Departemen Ilmu Gizi, Fakultas Kedokteran, Universitas Diponegoro, SemarangFakultas Kedokteran, Universitas Diponegoro, SemarangDepartemen Ilmu Gizi, Fakultas Kedokteran, Universitas Diponegoro, SemarangDepartemen Farmakologi dan Terapi, Fakultas Kedokteran, Universitas Diponegoro, SemarangDepartemen Ilmu Gizi, Fakultas Kedokteran, Universitas Diponegoro, SemarangCirrhosis is the final stage of all chronic liver diseases. Complications that occur are malnutrition. Administration of Hepatogomax as an enteral formula with adequate nutrients, specifically Branched-Chain Amino Acids (BCAA) and Medium-chain Triglyceride (MCT), can reduce serum ALP, bilirubin, and GG levels. This study aimed to determine the effect of hepatogomax in different doses on serum ALP, bilirubin, and GG levels. The study used the True Experimental post-test group design. Twenty-four male rats were divided into control group K normal and K(-) cirrhotic, treatment groups P1 and P2, given TAA and hepatogomax induction, respectively, at doses of 4,87 g/200gBW/day and 14,6 g/200gBW/day. Intervention for 28 days at the PAU Laboratory, Gadjah Mada University, February 2022 to April 2022. Statistical analysis used the Kruskal Wallis and Mann Whitney Post Hoc tests. The data is the result of examining serum levels after the intervention. The results showed significant differences in ALP, bilirubin, and GGT (p<0,05) in the group of rats induced by TAA intervention with hepatogomax compared to those not given hepatogomax. There was no significant difference in the decrease in serum ALP levels between the K normal (p<0,05) and P2 (p>0,05) groups. Giving hepatogomax at a dose of 14,6 g/200BB/day reduced serum ALP, bilirubin, and GG levels. In conclusion, Hepatogomax decreased ALP, bilirubin, and GGT serum levels in rats with cirrhosis. The most significant decrease in serum ALP, bilirubin, and GGT levels was observed at the P2 dose.https://ejournal.poltekkesaceh.ac.id/index.php/an/article/view/969alp, bilirubin, cirrhosis, hepatogomax, ggt, malnutrition |
| spellingShingle | Elfrida Sianturi Hery Djagat Purnomo Adriyan Pramono Endang Mahati Etika R. Noer Effect of hepatogomax on serum alkaline phosphatase, bilirubin, gamma-glutamyl transferase levels in Sprague Dawley rats cirrhosis AcTion: Aceh Nutrition Journal alp, bilirubin, cirrhosis, hepatogomax, ggt, malnutrition |
| title | Effect of hepatogomax on serum alkaline phosphatase, bilirubin, gamma-glutamyl transferase levels in Sprague Dawley rats cirrhosis |
| title_full | Effect of hepatogomax on serum alkaline phosphatase, bilirubin, gamma-glutamyl transferase levels in Sprague Dawley rats cirrhosis |
| title_fullStr | Effect of hepatogomax on serum alkaline phosphatase, bilirubin, gamma-glutamyl transferase levels in Sprague Dawley rats cirrhosis |
| title_full_unstemmed | Effect of hepatogomax on serum alkaline phosphatase, bilirubin, gamma-glutamyl transferase levels in Sprague Dawley rats cirrhosis |
| title_short | Effect of hepatogomax on serum alkaline phosphatase, bilirubin, gamma-glutamyl transferase levels in Sprague Dawley rats cirrhosis |
| title_sort | effect of hepatogomax on serum alkaline phosphatase bilirubin gamma glutamyl transferase levels in sprague dawley rats cirrhosis |
| topic | alp, bilirubin, cirrhosis, hepatogomax, ggt, malnutrition |
| url | https://ejournal.poltekkesaceh.ac.id/index.php/an/article/view/969 |
| work_keys_str_mv | AT elfridasianturi effectofhepatogomaxonserumalkalinephosphatasebilirubingammaglutamyltransferaselevelsinspraguedawleyratscirrhosis AT herydjagatpurnomo effectofhepatogomaxonserumalkalinephosphatasebilirubingammaglutamyltransferaselevelsinspraguedawleyratscirrhosis AT adriyanpramono effectofhepatogomaxonserumalkalinephosphatasebilirubingammaglutamyltransferaselevelsinspraguedawleyratscirrhosis AT endangmahati effectofhepatogomaxonserumalkalinephosphatasebilirubingammaglutamyltransferaselevelsinspraguedawleyratscirrhosis AT etikarnoer effectofhepatogomaxonserumalkalinephosphatasebilirubingammaglutamyltransferaselevelsinspraguedawleyratscirrhosis |